UBS (Lux) Equity Fund - Biotech Q Fonds
86,91
EUR
+1,13
EUR
+1,32
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Vertex Pharmaceuticals Inc | US92532F1003 | 10,03% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 7,60% |
| AbbVie Inc | US00287Y1091 | 5,98% |
| Gilead Sciences Inc | US3755581036 | 5,46% |
| Neurocrine Biosciences Inc | US64125C1099 | 5,26% |
| Amgen Inc | US0311621009 | 4,64% |
| Guardant Health Inc | US40131M1099 | 4,02% |
| Royalty Pharma PLC Class A | GB00BMVP7Y09 | 3,22% |
| Roivant Sciences Ltd Ordinary Shares | BMG762791017 | 3,19% |
| Sandoz Group AG Registered Shares | CH1243598427 | 3,16% |
| Sonstige | 47,45% |